MyAverix Finance
F · Healthcare
BIOCYTOGEN PHARMA. H YC1 (I54)
Biotechnology
BIOCYTOGEN PHARMA. H YC1 (I54) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $2.42B, P/E ratio is 109.00, net margin is 18.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for I54
BIOCYTOGEN PHARMA. H YC1 (I54) — FAQ
What is BIOCYTOGEN PHARMA. H YC1's market cap?
BIOCYTOGEN PHARMA. H YC1 (I54) has a reported market cap of $2.42B (data as of 2026-05-22).
What is I54's P/E ratio?
The price-to-earnings (P/E) ratio for BIOCYTOGEN PHARMA. H YC1 (I54) is 109.00 (data as of 2026-05-22).
Does BIOCYTOGEN PHARMA. H YC1 pay a dividend?
Dividend yield is not available in the current snapshot for BIOCYTOGEN PHARMA. H YC1 (I54). Check the MyAverix Finance app for the latest dividend data.
What sector is BIOCYTOGEN PHARMA. H YC1 in?
BIOCYTOGEN PHARMA. H YC1 (I54) is classified in the Healthcare sector (Biotechnology industry).
What exchange is I54 listed on?
I54 is listed on F.
What is BIOCYTOGEN PHARMA. H YC1's net margin?
BIOCYTOGEN PHARMA. H YC1 (I54) reports a net margin of 18.6% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.